×
About 11,688 results

ALLMedicine™ Portal Hypertension Center

Research & Reviews  5,703 results

Evaluation of Schistosomiasis Mansoni Morbidity by Hepatic and Splenic Elastography.
https://doi.org/10.1016/j.ultrasmedbio.2021.01.022
Ultrasound in Medicine & Biology; Pereira CLD, Santos JC et. al.

Feb 23rd, 2021 - In patients with Mansoni schistosomiasis, it is fundamental to evaluate the disease morbidity, which is reflected by the severity of periportal fibrosis (PPF) and parameters of portal hypertension, as analyzed by ultrasonography (US). This study a...

Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique ...
https://doi.org/10.1097/MD.0000000000024783
Medicine Meine TC, Maschke SK et. al.

Feb 20th, 2021 - To evaluate the feasibility and potential value of 2D Parametric Parenchymal Blood Flow (2D-PPBF) for the assessment of perfusion changes following partial spleen embolization (PSE) in a retrospective observational study design.Overall, 12 PSE pro...

Reliable Detection of Intrapulmonary Shunts Using Contrast Enhanced Echocardiography in...
https://doi.org/10.1097/MPG.0000000000003079
Journal of Pediatric Gastroenterology and Nutrition; Rock NM, Beghetti M et. al.

Feb 19th, 2021 - The aim of this study was to analyze if contrast-enhanced echocardiography (CEE) is as reliable as lung perfusion scintigraphy (LPS) to detect intrapulmonary shunting (IPS) in children with portal hypertension (PHTN) or congenital/surgical portosy...

Renoportal Anastomosis during Liver Transplantation in Patients with Portal Vein Thromb...
https://doi.org/10.1097/SLA.0000000000004797
Annals of Surgery; Azoulay D, Quintini C et. al.

Feb 19th, 2021 - To evaluate the short- and long-term outcomes of renoportal anastomosis (RPA) in a large multicentric series. The current knowledge on RPA for portal reconstruction during liver transplantation (LT) in patients with diffuse portal vein thrombosis ...

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients ...
https://doi.org/10.14309/ajg.0000000000001158
The American Journal of Gastroenterology; Tosetti G, Degasperi E et. al.

Feb 19th, 2021 - Nonselective β-blockers improve decompensation-free survival in viremic hepatitis C virus compensated cirrhotic patients with clinically significant portal hypertension, but their protective role after sustained virological response by direct-acti...

see more →

Guidelines  19 results

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hyperte...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306985
Gut Tripathi D, Stanley AJ et. al.

Mar 2nd, 2020 - These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG...

Imaging of Kidney Cysts and Cystic Kidney Diseases in Children: An International Working Gro...
https://pubs.rsna.org/doi/full/10.1148/radiol.2018181243

Dec 31st, 2018 - Kidney cysts can manifest as focal disease (simple and complex kidney cysts), affect a whole kidney (eg, multicystic dysplastic kidney or cystic dysplasia), or manifest as bilateral cystic disease (eg, autosomal recessive polycystic kidney disease.

ACR Appropriateness Criteria® Nonvariceal Upper Gastrointestinal Bleeding.
https://doi.org/10.1016/j.jacr.2017.02.038
Journal of the American College of Radiology : JACR; , Singh-Bhinder N et. al.

May 5th, 2017 - Upper gastrointestinal bleeding (UGIB) remains a significant cause of morbidity and mortality with mortality rates as high as 14%. This document addresses the indications for imaging UGIB that is nonvariceal and unrelated to portal hypertension. T...

ACR Appropriateness Criteria Nonvariceal Upper Gastrointestinal Bleeding
https://www.jacr.org/article/S1546-1440(17)30221-1/fulltext
Singh-Bhinder, N.

Apr 30th, 2017 - Upper gastrointestinal bleeding (UGIB) remains a significant cause of morbidity and mortality with mortality rates as high as 14%. This document addresses the indications for imaging UGIB that is nonvariceal and unrelated to portal hypertension.

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2...
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.28906

Oct 26th, 2016 - This guidance provides a data‐supported approach to risk stratification, diagnosis, and management of patients with cirrhosis and portal hypertension (PH). A guidance document is different from a guideline.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  5,819 results

Evaluation of Schistosomiasis Mansoni Morbidity by Hepatic and Splenic Elastography.
https://doi.org/10.1016/j.ultrasmedbio.2021.01.022
Ultrasound in Medicine & Biology; Pereira CLD, Santos JC et. al.

Feb 23rd, 2021 - In patients with Mansoni schistosomiasis, it is fundamental to evaluate the disease morbidity, which is reflected by the severity of periportal fibrosis (PPF) and parameters of portal hypertension, as analyzed by ultrasonography (US). This study a...

Evaluation of perfusion changes using a 2D Parametric Parenchymal Blood Flow technique ...
https://doi.org/10.1097/MD.0000000000024783
Medicine Meine TC, Maschke SK et. al.

Feb 20th, 2021 - To evaluate the feasibility and potential value of 2D Parametric Parenchymal Blood Flow (2D-PPBF) for the assessment of perfusion changes following partial spleen embolization (PSE) in a retrospective observational study design.Overall, 12 PSE pro...

Reliable Detection of Intrapulmonary Shunts Using Contrast Enhanced Echocardiography in...
https://doi.org/10.1097/MPG.0000000000003079
Journal of Pediatric Gastroenterology and Nutrition; Rock NM, Beghetti M et. al.

Feb 19th, 2021 - The aim of this study was to analyze if contrast-enhanced echocardiography (CEE) is as reliable as lung perfusion scintigraphy (LPS) to detect intrapulmonary shunting (IPS) in children with portal hypertension (PHTN) or congenital/surgical portosy...

Renoportal Anastomosis during Liver Transplantation in Patients with Portal Vein Thromb...
https://doi.org/10.1097/SLA.0000000000004797
Annals of Surgery; Azoulay D, Quintini C et. al.

Feb 19th, 2021 - To evaluate the short- and long-term outcomes of renoportal anastomosis (RPA) in a large multicentric series. The current knowledge on RPA for portal reconstruction during liver transplantation (LT) in patients with diffuse portal vein thrombosis ...

Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients ...
https://doi.org/10.14309/ajg.0000000000001158
The American Journal of Gastroenterology; Tosetti G, Degasperi E et. al.

Feb 19th, 2021 - Nonselective β-blockers improve decompensation-free survival in viremic hepatitis C virus compensated cirrhotic patients with clinically significant portal hypertension, but their protective role after sustained virological response by direct-acti...

see more →

News  143 results

Rifaximin May Prevent Hepatic Encephalopathy After TIPS Placement for Cirrhosis
https://www.medscape.com/viewarticle/945312

Feb 4th, 2021 - NEW YORK (Reuters Health) - The antibiotic rifaximin given before and after transjugular intrahepatic portosystemic shunt (TIPS) placement helped prevent hepatic encephalopathy (HE) in a placebo-controlled trial. "TIPS is a very effective treatmen...

Tools Emerging to Predict Liver Failure in Cirrhosis
https://www.staging.medscape.com/viewarticle/937030

Sep 7th, 2020 - Systemic inflammation and portal hypertension are key predictors of acute-on-chronic liver failure (ACLF) in the 3 months after a hospital stay for acute decompensated cirrhosis and also of death after 12 months, a preliminary analysis of data fro...

Tools Emerging to Predict Liver Failure in Cirrhosis
https://www.medscape.com/viewarticle/937030

Sep 7th, 2020 - Systemic inflammation and portal hypertension are key predictors of acute-on-chronic liver failure (ACLF) in the 3 months after a hospital stay for acute decompensated cirrhosis and also of death after 12 months, a preliminary analysis of data fro...

Belapectin misses endpoints in NASH trial
https://www.mdedge.com/gihepnews/article/218838/hepatology/belapectin-misses-endpoints-nash-trial?channel=346
Amy Karon, MDedge News

Mar 11th, 2020 - For patients with nonalcoholic steatohepatitis (NASH) with cirrhosis and portal hypertension, belapectin therapy was safe but did not significantly improve fibrosis or hepatic venous pressure gradient, compared with placebo, according to the resul.

Would you recognize this ‘invisible’ encephalopathy?
https://www.mdedge.com/psychiatry/article/208763/alzheimers-cognition/would-you-recognize-invisible-encephalopathy?channel=26934
Lee M. Flowers, MD, MPH

Oct 1st, 2019 - Mr. Z, an obese adult with a history of portal hypertension and cirrhosis from alcoholism, visits your clinic because he is having difficulty sleeping and concentrating at work.

see more →

Patient Education  3 results see all →